LLY Lilly Endowment plans $343.9M sale; WMT Walton Foundation…

▸ THE ONE-LINER

Someone inside Robinhood just unloaded $21.6M of HOOD stock. Discretionary or pre-planned, that's a number that earns a second look.

A 10% owner moved $21.6M out of HOOD this week. Discretionary, no pre-planned schedule behind it. At $98.69, the stock sits in the middle of its 52-week range, well off the $154 high but comfortably above the $64 floor, which makes the timing less obvious than a peak-price exit. The position sold represents 5.0% of holdings, not a full exit but not a trim either.

Zimmer Biomet refinanced its credit facility, terminating the old agreement and replacing it with a new material definitive arrangement that creates a direct financial obligation. The timing lands with ZBH sitting near the lower half of its 52-week range at $93, suggesting the company moved to lock in terms before any rate environment shifts. New debt structure changes the liability profile, and the credit terms will shape how much flexibility Zimmer has for acquisitions or balance sheet moves ahead.

Martin Marietta Materials entered into a material definitive agreement involving unregistered equity sales, suggesting a private placement or debt-linked equity transaction outside standard registration. The filing's combination of Items 1.01 and 3.02 points to a structured deal that bypassed public markets, likely tied to an acquisition or financing arrangement. With MLM sitting near the middle of its 52-week range, investors will want to see the attached exhibits to understand dilution risk and what this capital is funding.

Honeywell completed the spinoff of its Advanced Materials segment into a standalone public company, a transaction that reshapes the parent into a more focused industrial and aerospace business. The filing covers nearly every major 8-K category, from leadership changes and bylaw amendments to modified shareholder rights, suggesting a comprehensive corporate restructuring rather than a single clean cut. With HON sitting near the upper half of its 52-week range, investors will now watch whether the leaner Honeywell can justify a premium valuation through improved margins and faster growth.

SPREAD THE FILE

KNOW SOMEONE WHO
TRACKS THE INSIDERS?